Oncología radioterápica

2018

1. Analysis of predictors of pain response in patients with bone metastasis undergoing palliative radiotherapy: Does age matter?

   Journal of Medical Imaging and Radiation Oncology, Vol. 62, Núm. 4, pp. 578-584

2. Concurrent chemoradiation for locally advanced stage III non-small cell lung cancer with cisplatin, vinorelbine, and thoracic radiotherapy: a phase II study from the Galician Lung Cancer Group

   Clinical and Translational Oncology, Vol. 20, Núm. 11, pp. 1467-1473

3. Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants

   Nature Communications, Vol. 9, Núm. 1

4. Germline variation at 8q24 and prostate cancer risk in men of European ancestry

   Nature Communications, Vol. 9, Núm. 1

5. Neoadjuvant treatment followed by surgery versus definitive chemoradiation in stage IIIA-N2 non-small-cell lung cancer: A multi-institutional study by the oncologic group for the study of lung cancer (Spanish Radiation Oncology Society)

   Lung Cancer, Vol. 118, pp. 119-127

6. Response to: Low level evidence supporting the choice of optimal multimodality treatment approach in patients with stage IIIA NSCLC- ain't no mountain high enough…. to keep me getting to you by Jeremic Branislav

   Lung Cancer

7. Treatment Design and Rationale for a Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for SCLC: PREMER Trial on Behalf of the Oncologic Group for the Study of Lung Cancer/Spanish Radiation Oncology Group-Radiation Oncology Clinical Research Group

   Clinical Lung Cancer, Vol. 19, Núm. 5, pp. e693-e697